Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Correction ... Goodman added more

<< Previous

Bullboard Posts

Next >>

Post by MrMugsyon Nov 23, 2021 7:31am

152 Views

Post# 34155958

Correction ... Goodman added more

Correction ... add another 18,000 shares to Goodman's holdings ... came through a little later.
That's a lot of insider activity

Filed 2021-11-22 22:19 Tx date 2021-11-22	$GUD Knight Therapeutics Inc.	Long Zone Holdings Inc. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$95,220 +18,000 vol $5.29 each	21,685,133
Filed 2021-11-22 16:55 Tx date 2021-11-22	$GUD Knight Therapeutics Inc.	Goodman, Jonathan Ross 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,184 +800 vol $5.23 each	672,984
Filed 2021-11-22 16:52 Tx date 2021-11-22	$GUD Knight Therapeutics Inc.	Goodman, Jonathan Ross 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder Holder: Long Zone Holdings Inc. (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$95,220 +18,000 vol $5.29 each	21,541,233